As the Ebola outbreak winds down in West Africa, with no cases reported again last week, researchers reported new findings about complications in survivors and about clinical trial findings for one of the candidate...
A prophylactic hepatitis C virus (HCV) vaccine produces a long-lasting, sustained T-cell response that is characteristic of the T-cell response associated with a controlled HCV infection. Researchers have evaluated the...